Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease

Código QR

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease

Objective: We performed a single-center retrospective study to determine the different efficacy of tocilizumab (TCZ) in the early and late stages and in three phenotypic subgroups (monocyclic, polycyclic, and persistent) of systemic juvenile idiopathic arthritis (sJIA).Methods: Clinical and serologi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xin Yan, Wenjing Tang, Zhiyong Zhang, Yu Zhang, Chong Luo, Xuemei Tang
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	systemic juvenile idiopathic arthritis tocilizumab clinical trial pediatric treatment Pediatrics RJ1-570
Acceso en línea:	https://doaj.org/article/1120430879074bf395aa0d1116885345
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Does Juvenile Idiopathic Arthritis Affect the Course of Legg–Calvé–Perthes Disease? A Case-Control Study with a Mean Follow-Up of 8 Years
por: Julien Roß, et al.
Publicado: (2021)

Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
por: Lubov S. Sorokina, et al.
Publicado: (2021)

How children with juvenile idiopathic arthritis view participation and communication in healthcare encounters: a qualitative study
por: Veronica Lundberg, et al.
Publicado: (2021)

Magnetic resonance imaging of the knee joint in juvenile idiopathic arthritis
por: Emil Michalski, et al.
Publicado: (2020)

COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity
por: Oksana Boyarchuk, et al.
Publicado: (2021)

Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
por: Yaryna Boyko, et al.
Publicado: (2020)

Uveitis associated juvenile idiopathic arthritis – presentation of recently published international recommendations for diagnostic and therapeutic procedures
por: Lidia Rutkowska-Sak, et al.
Publicado: (2020)

The use of radiosynovectomy in patients with juvenile idiopathic arthritis. Assessment of treatment efficacy and safety
por: Agnieszka Gazda, et al.
Publicado: (2021)

Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis
por: Taha R, et al.
Publicado: (2019)

Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series
por: Oksana Boyarchuk, et al.
Publicado: (2020)

Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey
por: Sibel Balcı, et al.
Publicado: (2020)

Best practices for recruitment of adolescents for biobanking and precision health research: a retrospective analysis comparing juvenile idiopathic arthritis cases with healthy controls
por: Kimberly A. Lewis, et al.
Publicado: (2021)

Psycho-emotional condition of young adults with juvenile idiopathic arthritis
por: M.B. Dzhus
Publicado: (2017)

Serum Calprotectin a Potential Biomarker in Juvenile Idiopathic Arthritis: A Meta-Analysis
por: Emma Altobelli, et al.
Publicado: (2021)

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies
por: Amal Saki, et al.
Publicado: (2021)

Present day therapy of juvenile idiopathic arthritis with the use of genetically engineered medicines in a third level regional hospital - results and problems
por: A. E. Matyunova, et al.
Publicado: (2017)

A young girl with severe polyarteritis nodosa successfully treated with tocilizumab: a case report
por: Margaux Boistault, et al.
Publicado: (2021)

A novel transition clinic structure for adolescent and young adult patients with childhood onset rheumatic disease improves transition outcomes
por: Rebecca S. Overbury, et al.
Publicado: (2021)

Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report
por: Anjumanara Anver Omar, et al.
Publicado: (2021)

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
por: Farah Z, et al.
Publicado: (2016)

Juvenile Idiopathic Arthritis and COVID-19 Pandemic: Good Compliance With Treatment, Reluctance to Return to School
por: Baptiste Quéré, et al.
Publicado: (2021)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
por: Cimmino MA, et al.
Publicado: (2020)

Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
por: Federica Filippi, et al.
Publicado: (2019)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii N, et al.
Publicado: (2021)

The family journey-to-diagnosis with systemic juvenile idiopathic arthritis: a cross-sectional study of the changing social media presence
por: Modica RF, et al.
Publicado: (2016)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci M, et al.
Publicado: (2016)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
por: Bullement A, et al.
Publicado: (2021)

Regulatory T cell function in autoimmune disease
por: Anandi Rajendeeran, et al.
Publicado: (2021)

Metabolic syndrome in adults with a history of juvenile arthritis
por: Sule S, et al.
Publicado: (2018)

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies
por: Alberto Enrico Maraolo, et al.
Publicado: (2021)

Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
por: Bogna Grygiel-Górniak, et al.
Publicado: (2021)

JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND ITS ASSOCIATION WITH CLINICAL DISEASE ACTIVITY IN LAHORE
por: Zanera Nawaz, et al.
Publicado: (2018)

MRI Findings in Hip in Juvenile Idiopathic Arthritis
por: Monika Ostrowska, et al.
Publicado: (2021)

Euphorbia Factor L2 ameliorates the Progression of K/BxN Serum-Induced Arthritis by Blocking TLR7 Mediated IRAK4/IKKβ/IRF5 and NF-kB Signaling Pathways
por: Jing Tang, et al.
Publicado: (2021)

The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Wan-Tong Zhang, et al.
Publicado: (2021)

The Type of Conservative Management Could Be Related to the Strength of the Inspiratory Muscles of Adolescents with Idiopathic Scoliosis—A Case Series
por: Felipe León-Morillas, et al.
Publicado: (2021)

Impact of systemic juvenile idiopathic arthritis/Still’s disease on adolescents as evidenced through social media posts
por: Modica RF, et al.
Publicado: (2018)

Psoriasis in children
por: Pinson R, et al.
Publicado: (2016)

Slow speed resistance exercise training in children with polyarticular juvenile idiopathic arthritis
por: Sule SD, et al.
Publicado: (2019)

Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19
por: Infante Barbara, et al.
Publicado: (2021)